HealthTech Business — Business Valuation Multiple
EBITDA Valuation Guide · Small & Mid-Sized Businesses
Actual EBITDA multiples can vary materially based on EBITDA size, growth, recurring revenue, margins, customer concentration, owner dependence, geography and other company-specific factors.
Min
5×
Typical
7×
Max
10×
Revenue Model
Mixed
Capital Intensity
Varies
A typical multiple of 7× EBITDA reflects mid-market transactions in the $1–$50M revenue range.
Overview
Healthcare technology businesses typically trade at 5×–10× EBITDA. Partnerships with healthcare providers, regulatory approval, and recurring SaaS licence models underpin strong valuations. A large addressable market and strong clinical evidence base attract strategic buyers. Healthcare procurement cycle delays, clinical validation requirements, and data security obligations are the main risk factors.
Key Value Drivers
- Healthcare provider partnerships
- Regulatory approval and certification
- Recurring SaaS licence model
- Strong clinical evidence base
- Large addressable market
Key Risks
- Healthcare procurement cycle and budget delays
- Clinical validation and regulatory risk
- Data security and privacy obligations
- Competition from established MedTech players
- Reimbursement pathway complexity
Related Industries
Disclaimer: All multiples are indicative estimates only and are not formal valuations or investment advice. They should not be relied upon for financial decision-making without independent professional advice.